16
Participants
Start Date
March 31, 2005
Primary Completion Date
April 30, 2011
Study Completion Date
April 30, 2011
EBNA1 C-terminal/LMP2 chimeric protein-expressing recombinant modified vaccinia Ankara vaccine
laboratory biomarker analysis
pharmacological study
University of Birmingham, Birmingham
Royal Marsden - London, London
Christie Hospital, Manchester
Lead Sponsor
Cancer Research UK
OTHER